AMTAGVI 72000000000 1/500mL
lifileucel · SUSPENSION · Iovance Biotherapeutics Inc.
No Recall History
Plain English
AMTAGVI is a suspension containing lifileucel at 72000000000 1/500mL, taken intravenous. Manufactured by Iovance Biotherapeutics Inc..
Key Facts
- Brand Name
- AMTAGVI
- Generic Name
- lifileucel
- NDC Code (Product)
73776-001- Manufacturer
- Iovance Biotherapeutics Inc.
- Strength
- 72000000000 1/500mL
- Dosage Form
- SUSPENSION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125773
- Marketing Start
- 02/16/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is AMTAGVI used for?
AMTAGVI contains lifileucel. It is a suspension taken intravenous. Consult your doctor for specific uses.
Is AMTAGVI a controlled substance?
AMTAGVI is not classified as a controlled substance by the DEA.
What is the generic name for AMTAGVI?
The generic name for AMTAGVI is lifileucel. There are no other listed brand versions of lifileucel.
What is the NDC code for AMTAGVI 72000000000 1/500mL?
The NDC (National Drug Code) for AMTAGVI 72000000000 1/500mL is 73776-001, listed by Iovance Biotherapeutics Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)